@SecureIBD

SECURE-IBD is an international database that captured the natural history and outcomes of #COVID19 occurring in #IBD patients from March 2020 to January 2022.

 UNC- Chapel Hill
covidibd.org
Joined April 2020
  • Tweets96
  • Following131
  • Followers754
2Media
Our analysis on the impact of #IBD medications in >6000 patients with #COVID19 in our registry is out in @AGA_Gastro!
Ryan Ungaro MD MS@ryanungaro14 Sep 2021
Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of Over 6,000 Patients from an International Registry. Latest from SECURE-IBD. gastrojournal.org/article/S0…

Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than...

The Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) database, an international, collaborative database created to monitor COVID-19...

gastrojournal.org
1
2
13
It is time to close down reporting to the SECURE-IBD database. We are proud of SECURE-IBD’s contributions and incredibly grateful for your help. This initiative was not possible without the support of the entire #IBD community. covidibd.org
5
9
1
70
@EJBrenner_MD @ManasiAgrawalMD @ryanungaro @MichaelKappel12 @JeanFredericCo1 @Siew_C_Ng @gilkaplan @Flaviostein @JamesLewisGIEpi @IOIBD1 @CrohnsColitisFn @NASPGHAN @Y_ECCO_IBD
1
1
Great talk by ⁦@ryanungaro⁩ ⁦@SecureIBD⁩ on COVID-IBD. Disease activity and steroids biggest risk factors for poor outcomes. ⁦@ucsfibd⁩
1
3
7
The strength of collaboration! Study pooling data on TNFi +/- other therapies and #COVID19 outcomes in >6000 patients with immune-mediated inflammatory diseases @rheum_covid @PsoProtect
JAMA Network Open@JAMANetworkOpen18 Oct 2021
Pooled results from @rheum_covid, @SecureIBD, and @PsoProtect, representing >6000 patients with immune-mediated inflammatory disease and #COVID19, support TNFi monotherapy use during the pandemic. @IzadiZara @EJBrenner_MD @JYazdanyMD @MichaelKappel12 ja.ma/3ATO9ZC
1
5
Great collaboration with @amandaricciuto @ericbenchimol @DrNickKennedy @ibdseb and others!
Eric Benchimol@ericbenchimol28 Sep 2021
New @SecureIBD study from @amandaricciuto at @SickKidsNews IBD Centre: younger patients w.more severe inflammation at-risk for severe #COVID19 (controlling for medications) @gilkaplan @MichaelKappel12 @ManasiAgrawalMD @EJBrenner_MD @ekuenzig @DrNickKennedy academic.oup.com/ecco-jcc/ad…
2
1
11
New GI symptoms in individuals with #IBD who get #COVID19 do not correlate with death or other severe outcomes. Read our new pub here 👉🏻 academic.oup.com/ibdjournal/… @ryanungaro @ManasiAgrawalMD @EJBrenner_MD @MichaelKappel12 @JeanFredericCo1

New Gastrointestinal Symptoms Are Common in Inflammatory Bowel Disease Patients With COVID-19: Data...

Coronavirus disease 2019 (COVID-19) can cause gastrointestinal (GI) symptoms. A prior meta-analysis suggested that up to 17.6% of COVID-19 patients have GI

academic.oup.com
4
9
Replying to @EJBrenner_MD
@EJBrenner_MD and @ManasiAgrawalMD on #COVID19 outcomes and racial disparities among #IBD populations 🔊ow.ly/mh1D50Fui7m @SecureIBD @wingyanjoyce @gilkaplan @Siew_C_Ng @Flaviostein @JamesLewisGIEpi @HuntKissous @IreneModesto @ryanungaro @JeanFredericCo1 @MichaelKappel12
microphone, audio, recording

ALT microphone, audio, recording

2
3
Rajen Parekh, a recent high school graduate, reported on the impact of individual comorbid conditions on #COVID19 outcomes in #IBD @DDS_Journal What an accomplishment! pubmed.ncbi.nlm.nih.gov/3418… @EJBrenner_MD @ryanungaro @ManasiAgrawalMD @JeanFredericCo1 @MichaelKappel12

Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammat...

Many non-IBD comorbidities are associated with a two to threefold increased risk of COVID-19 hospitalization or death among patients with IBD. These data can be used to risk-stratify and guide...

pubmed.ncbi.nlm.nih.gov
2
11
Disparities in #COVID19 outcomes by race and ethnicity, now published in @AGA_CGH ➡️Hispanic & non-Hispanic black individuals with #IBD had worse #COVID19 outcomes ➡️driven in part by non-IBD comorbidities cghjournal.org/article/S1542…
1
6
1
8
➡️a reminder to take into account social determinants of health in clinical practice ➡️emphasizes the urgent need for policy change towards equitable healthcare for all Health is a human right.
1
3
4
@ManasiAgrawalMD @EJBrenner_MD @wingyanjoyce @Siew_C_Ng @gilkaplan @Flaviostein @JamesLewisGIEpi @JeanFredericCo1 @MichaelKappel12
Dr @MichaelKappel12 discussing Outcomes in Patients with #IBD and #COVID19 by Age #DDW21 #DDW2021 @secureIBD
1
3
NEW GASTROINTESTINAL SYMPTOMS ARE COMMON IN... by @ryanungaro DDW ePoster Library; May 21 2021; 319648 eposters.ddw.org/ddw/2021/dd… @EJBrenner_MD @ManasiAgrawalMD @MichaelKappel12 @JeanFredericCo1

NEW GASTROINTESTINAL SYMPTOMS ARE COMMON IN INFLAMMATORY BOWEL... by Ryan Ungaro

DDW ePoster Library; Ungaro R. May 21 2021; 319648;

eposters.ddw.org
5
COVID-19 OUTCOMES AMONG RACIAL AND ETHNIC... by @EJBrenner_MD DDW ePoster Library; May 21 2021; 319659 Poster of Distinction! eposters.ddw.org/ddw/2021/dd… @ManasiAgrawalMD @ryanungaro @wingyanjoyce @Siew_C_Ng @gilkaplan @JeanFredericCo1 @MichaelKappel12

COVID-19 OUTCOMES AMONG RACIAL AND ETHNIC MINORITY INDIVIDUALS WITH... by Dr. Erica Brenner

DDW ePoster Library; Brenner E. May 21 2021; 319659;

eposters.ddw.org
1
7
THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19... by @ManasiAgrawalMD DDW ePoster Library; May 21 2021; 319644 eposters.ddw.org/ddw/2021/dd… @EJBrenner_MD @ryanungaro @MichaelKappel12 @JeanFredericCo1

THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD... by Dr. Manasi Agrawal

DDW ePoster Library; Agrawal M. May 21 2021; 319644;

eposters.ddw.org
4
THE EFFECTS OF COMORBIDITIES ON COVID-19... by Rajen Parekh DDW ePoster Library; May 21 2021; 319646 eposters.ddw.org/ddw/2021/dd… @EJBrenner_MD @MichaelKappel12 @ryanungaro @ManasiAgrawalMD @JeanFredericCo1

THE EFFECTS OF COMORBIDITIES ON COVID-19 OUTCOMES AMONG PATIENTS... by Rajen Parekh

DDW ePoster Library; Parekh R. May 21 2021; 319646;

eposters.ddw.org
5
Secure IBD retweeted
Millie Long@MLongMD29 Apr 2021
We are pleased to report that we have hit the 3000 mark in IBD patients enrolled in PREVENT COVID (a study of COVID-19 vaccination). Our team pledges to share results with patients in real time. Check out preliminary results here (>90% with titers) ibdpartners.org/preventcovid…
7
31
11
149
Read our paper on VDZ outcomes in #IBD, out in JCC @Y_ECCO_IBD 👉🏻Compared to all other meds, VDZ use was not a/w hospitalization or severe #COVID19 👉🏻Compared to TNFi monotherapy, VDZ monotherapy was a/w hospitalization, but not severe #COVID19 academic.oup.com/ecco-jcc/ad…
1
4
1
17
@ManasiAgrawalMD @EJBrenner_MD @ryanungaro @MichaelKappel12 @JeanFredericCo1
1
Load more